7578 related articles for article (PubMed ID: 1934088)
21. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors.
Gilg AG; Tye SL; Tolliver LB; Wheeler WG; Visconti RP; Duncan JD; Kostova FV; Bolds LN; Toole BP; Maria BL
Clin Cancer Res; 2008 Mar; 14(6):1804-13. PubMed ID: 18347183
[TBL] [Abstract][Full Text] [Related]
22. Altered expression and distribution of heparan sulfate proteoglycans in human gliomas.
Steck PA; Moser RP; Bruner JM; Liang L; Freidman AN; Hwang TL; Yung WK
Cancer Res; 1989 Apr; 49(8):2096-103. PubMed ID: 2522816
[TBL] [Abstract][Full Text] [Related]
23. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.
Tysnes BB; Haugland HK; Bjerkvig R
Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221
[TBL] [Abstract][Full Text] [Related]
25. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption.
Liau LM; Lallone RL; Seitz RS; Buznikov A; Gregg JP; Kornblum HI; Nelson SF; Bronstein JM
Cancer Res; 2000 Mar; 60(5):1353-60. PubMed ID: 10728698
[TBL] [Abstract][Full Text] [Related]
26. Surface antigenic characteristics of human glial brain tumor cells.
Wikstrand CJ; Mahaley MS; Bigner DD
Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus-mediated overexpression of Fas induces apoptosis of gliomas.
Shinoura N; Ohashi M; Yoshida Y; Kirino T; Asai A; Hashimoto M; Hamada H
Cancer Gene Ther; 2000 Feb; 7(2):224-32. PubMed ID: 10770630
[TBL] [Abstract][Full Text] [Related]
28. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
29. Nonexpression of CD15 by neoplastic glia: a barrier to metastasis?
Martin K; Akinwunmi J; Rooprai HK; Kennedy AJ; Linke A; Ognjenovic N; Pilkington GJ
Anticancer Res; 1995; 15(4):1159-66. PubMed ID: 7653994
[TBL] [Abstract][Full Text] [Related]
30. Products of cells from gliomas: IX. Evidence that two fundamentally different mechanisms change extracellular matrix expression by gliomas.
McKeever PE; Varani J; Papadopoulos SM; Wang M; McCoy JP
J Neurooncol; 1995; 24(3):267-80. PubMed ID: 7595757
[TBL] [Abstract][Full Text] [Related]
31. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
Wikstrand CJ; Bigner SH; Bigner DD
Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
[TBL] [Abstract][Full Text] [Related]
32. [Anti-tumor antibodies in the blood of patients with gliomas].
Martin-Achard A; Diserens AC; de Tribolet N; Zander E; Carrel S
Schweiz Med Wochenschr; 1978 Jun; 108(25):959-62. PubMed ID: 663586
[TBL] [Abstract][Full Text] [Related]
33. Morphological heterogeneity and phenotype modifications during long term in vitro cultures of six new human glioblastoma cell lines.
Dipasquale B; Colombatti M; Tridente G
Tumori; 1990 Apr; 76(2):172-8. PubMed ID: 2330609
[TBL] [Abstract][Full Text] [Related]
34. [Similarities between cultured human fetal glia cells and cell types from gliomas; cell culture studies].
Gazsó L; Pásztor E; Szeker J
Morphol Igazsagugyi Orv Sz; 1979 Jan; 19(1):48-53. PubMed ID: 219329
[TBL] [Abstract][Full Text] [Related]
35. Tumor immunology: a neurosurgical perspective. II. The immunology of glial neoplasms.
Apuzzo ML
Bull Los Angeles Neurol Soc; 1976 Oct; 41(4):176-83. PubMed ID: 74264
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies in neuro-oncology.
Stavrou D
Neurosurg Rev; 1990; 13(1):7-18. PubMed ID: 2181345
[TBL] [Abstract][Full Text] [Related]
37. Paucity of humoral response in patients to glioma-associated antigen(s): antigen localization by immunofluorescence.
Fischer DK; Matsuda M; Shaban F; Narayan RK; Atassi MZ
Adv Exp Med Biol; 1991; 303():263-70. PubMed ID: 1805570
[TBL] [Abstract][Full Text] [Related]
38. Factor analysis of the immunophenotypes of astrocytomas and malignant gliomas: correlations with tumor grade and patient survival.
Jennings MT; Asadourian LL; Jennings VD; Shapiro JR; Thaler HT
J Neurooncol; 1990 Dec; 9(3):265-73. PubMed ID: 2086740
[TBL] [Abstract][Full Text] [Related]
39. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays.
Coakham HB; Kornblith PL; Quindlen EA; Pollock LA; Wood WC; Hartnett LC
J Natl Cancer Inst; 1980 Feb; 64(2):223-33. PubMed ID: 6153405
[TBL] [Abstract][Full Text] [Related]
40. Antigen related to cell proliferation in malignant gliomas recognized by a human monoclonal antibody.
Kokunai T; Tamaki N; Matsumoto S
J Neurosurg; 1990 Dec; 73(6):901-8. PubMed ID: 2230972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
